Amneal Pharmaceuticals of New York, LLC is recalling 69,239 vials of Methylprednisolone Acetate Injectable Suspension, USP (80 mg/mL). The recall was initiated because the outer carton (secondary packaging) contains a typographical error in the National Drug Code (NDC). While the individual vials inside have the correct labeling, the outer cartons display an incorrect identification number. No incidents or injuries have been reported to date.
The typographical error on the outer packaging could lead to medication mismanagement or administrative errors at pharmacies and healthcare facilities. No medical injuries have been reported, and the individual vials contain the correct drug information.
Professional/Clinical return for sterile injectable.
Recall due to typographical error on secondary packaging: Carton incorrectly lists NDC 70121-1573-1.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.